Tuesday, June 20, 2017 2:28:14 PM
Went from riddling the company with
further debt and expense seeking an FDA designation with no real promise of approval, or benefit.....to....
Focusing on making money now....
AND RMAT IS STILL ON THE TABLE FOR THOSE WHO CANNOT READ
He had to tell shareholders somehow and some time about this new strategy, and given the obvious gut overreaction that has occurred for those that sold out, Friday at 5 was best.
I know I wanted to sell when I heard RMAT initially, that was gut reaction to news. Calmed down over weekend.
Looking forward to the steady gains as clinics open and more and more states approve right to try.
Research shows 13 other states have bills currently on the floor for the same.
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM